Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Amplyx Pharmaceuticals
company
About
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $53M
- Industries
- Biotechnology,Clinical Trials,Medical,Pharmaceutical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$53M
Amplyx Pharmaceuticals has raised a total of
$53M
in funding over 2 rounds. Their latest funding was raised on
May 19, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 19, 2020 | Series C | $53M | 1 | — | — | Detail |
| Jan 1, 2009 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Amplyx Pharmaceuticals is funded by 2 investors.
Pfizer
and Keiretsu Forum
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pfizer
|
— | Series C |
Keiretsu Forum
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
